M Barry1, F A Traoré2, F B Sako3, D O Kpamy1, E I Bah1, M Poncin4, S Keita5, M Cisse6, A Touré7. 1. Service des maladies infectieuses et tropicales, hôpital national Donka, CHU de Conakry, Quartier Cameroun, Conakry, Guinea. 2. Service des maladies infectieuses et tropicales, hôpital national Donka, CHU de Conakry, Quartier Cameroun, Conakry, Guinea; Chaire de dermatologie et maladies infectieuses, département de médecine, université de Conakry, Conakry, Guinea. Electronic address: fatraore01@gmail.com. 3. Service des maladies infectieuses et tropicales, hôpital national Donka, CHU de Conakry, Quartier Cameroun, Conakry, Guinea; Chaire de dermatologie et maladies infectieuses, département de médecine, université de Conakry, Conakry, Guinea. 4. Coordonateur projet MSF urgence Ebola, hôpital Donka, Conakry, Guinea. 5. Division de la prévention et de la lutte contre la maladie, ministère de la Santé, Guinea. 6. Chaire de dermatologie et maladies infectieuses, département de médecine, université de Conakry, Conakry, Guinea. 7. Chaire de santé publique, département de pharmacie, université de Conakry, Conakry, Guinea.
Abstract
OBJECTIVES: The authors studied the epidemiological, clinical, and outcome features of the Ebola virus disease in patients hospitalized at the Ebola treatment center (ETC) in Conakry to identify clinical factors associated with death. MATERIALS AND METHODS: A prospective study was conducted from March 25 to August 20, 2014. The diagnosis of Ebola virus infection was made on real-time PCR. RESULTS: Ninety patients, with a positive test result, were hospitalized. Their mean age was 34.12±14.29 years and 63% were male patients. Most worked in the informal sector (38%) and in the medical and paramedical staff (physicians 12%, nurses 6%, and laboratory technicians 1%). Most patients lived in the Conakry suburbs (74%) and in Boffa (11%). The main clinical signs were physical asthenia (80%) and fever (72%). Hemorrhagic signs were observed in 26% of patients. The comparison of clinical manifestations showed that hiccups (P=0.04), respiratory distress (P=0.04), and hemorrhagic symptoms (P=0.01) were more frequent among patients who died. Malaria (72%) and diabetes (2%) were the most frequent co-morbidities. The crude case fatality rate was 44% [95% confidence interval (33-54%)]. The average hospital stay was 7.96±5.81 days. CONCLUSION: The first Ebola outbreak in Conakry was characterized by the young age of patients, discrete hemorrhagic signs related to lethality. Its control relies on a strict use of preventive measures.
OBJECTIVES: The authors studied the epidemiological, clinical, and outcome features of the Ebola virus disease in patients hospitalized at the Ebola treatment center (ETC) in Conakry to identify clinical factors associated with death. MATERIALS AND METHODS: A prospective study was conducted from March 25 to August 20, 2014. The diagnosis of Ebola virus infection was made on real-time PCR. RESULTS: Ninety patients, with a positive test result, were hospitalized. Their mean age was 34.12±14.29 years and 63% were male patients. Most worked in the informal sector (38%) and in the medical and paramedical staff (physicians 12%, nurses 6%, and laboratory technicians 1%). Most patients lived in the Conakry suburbs (74%) and in Boffa (11%). The main clinical signs were physical asthenia (80%) and fever (72%). Hemorrhagic signs were observed in 26% of patients. The comparison of clinical manifestations showed that hiccups (P=0.04), respiratory distress (P=0.04), and hemorrhagic symptoms (P=0.01) were more frequent among patients who died. Malaria (72%) and diabetes (2%) were the most frequent co-morbidities. The crude case fatality rate was 44% [95% confidence interval (33-54%)]. The average hospital stay was 7.96±5.81 days. CONCLUSION: The first Ebola outbreak in Conakry was characterized by the young age of patients, discrete hemorrhagic signs related to lethality. Its control relies on a strict use of preventive measures.
Authors: Adam R Aluisio; Shiromi M Perera; Derrick Yam; Stephanie Garbern; Jillian L Peters; Logan Abel; Daniel K Cho; Stephen B Kennedy; Moses Massaquoi; Foday Sahr; Suzanne Brinkmann; Lindsey Locks; Tao Liu; Adam C Levine Journal: J Nutr Date: 2019-10-01 Impact factor: 4.798
Authors: Sian Reece; Colin S Brown; Jake Dunning; Meera A Chand; Maria C Zambon; Michael Jacobs Journal: Clin Med (Lond) Date: 2017-07 Impact factor: 2.659
Authors: M S Cherif; N Koonrungsesomboon; M P Diallo; E Le Gall; D Kassé; F Cherif; A Koné; M Diakité; F Camara; N Magassouba Journal: Eur J Clin Microbiol Infect Dis Date: 2016-11-25 Impact factor: 3.267
Authors: Adam R Aluisio; Shiromi M Perera; Derrick Yam; Stephanie Garbern; Jillian L Peters; Logan Abel; Daniel K Cho; Dayan Woldemichael; Stephen B Kennedy; Moses Massaquoi; Foday Sahr; Tao Liu; Adam C Levine Journal: Trop Med Int Health Date: 2020-01-22 Impact factor: 2.622
Authors: P S C Rees; L E M Lamb; T C Nicholson-Roberts; C N Ardley; M S Bailey; D E Hinsley; T E Fletcher; S J Dickson Journal: Intensive Care Med Date: 2015-03-12 Impact factor: 17.440
Authors: Robin Burk; Laura Bollinger; Joshua C Johnson; Jiro Wada; Sheli R Radoshitzky; Gustavo Palacios; Sina Bavari; Peter B Jahrling; Jens H Kuhn Journal: FEMS Microbiol Rev Date: 2016-06-05 Impact factor: 16.408
Authors: Hannah M Edwards; Helen Counihan; Craig Bonnington; Jane Achan; Prudence Hamade; James K Tibenderana Journal: PLoS One Date: 2021-05-24 Impact factor: 3.240
Authors: A Mailles; H Noel; D Pannetier; C Rapp; Y Yazdanpanah; S Vandentorren; P Chaud; J M Philippe; B Worms; M Bruyand; M Tourdjman; M Nahon; E Belchior; E Lucas; J Durand; M Zurbaran; S Vaux; B Coignard; H DE Valk; S Baize; S Quelet; F Bourdillon Journal: Epidemiol Infect Date: 2017-11-23 Impact factor: 4.434